# A Study of HDM1005 in Participants With Type 2 Diabetes Not Controlled With Diet and Exercise Alone

> **NCT07394114** · PHASE3 · RECRUITING · sponsor: **Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.** · enrollment: 240 (estimated)

## Conditions studied

- Type 2 Diabetes

## Interventions

- **DRUG:** HDM1005 1
- **DRUG:** HDM1005 2
- **DRUG:** HDM1005 injection or placebo

## Key facts

- **NCT ID:** NCT07394114
- **Lead sponsor:** Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-02-24
- **Primary completion:** 2027-08-28
- **Final completion:** 2027-12-17
- **Target enrollment:** 240 (ESTIMATED)
- **Last updated:** 2026-02-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07394114

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07394114, "A Study of HDM1005 in Participants With Type 2 Diabetes Not Controlled With Diet and Exercise Alone". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT07394114. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*